메뉴 건너뛰기




Volumn 58, Issue 4, 2002, Pages 293-297

Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands

Author keywords

Children; EMEA; Licensing

Indexed keywords

AMOXICILLIN; BUDESONIDE; CAFFEINE; CEFOTAXIME; CISAPRIDE; FOLIC ACID; IPRATROPIUM BROMIDE; PARACETAMOL; PREDNISOLONE; SALBUTAMOL; VITAMIN K GROUP; DRUG;

EID: 0036020410     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-002-0479-9     Document Type: Article
Times cited : (87)

References (23)
  • 16
    • 4243596727 scopus 로고    scopus 로고
    • January 2001 status report to Congress. Department of Health and Human Services. U.S. Food and Drug Administration, Washington
    • (2001) The pediatric exclusivity provision
  • 18
    • 0009768757 scopus 로고    scopus 로고
    • Anonymous (2000) Federal Register 21 CFR Part 201. Requirements on content and format of labeling for human prescription drugs and biologics: requirements of prescription drug product labels; proposed rule, 2000. U.S. Government Printing Office, Washington
  • 19
    • 0030020858 scopus 로고    scopus 로고
    • The European medicines evaluation agency
    • (1996) BMJ , vol.312 , pp. 394
    • Herxheimer, A.1
  • 20
    • 0034690444 scopus 로고    scopus 로고
    • Drug industry is unwilling to run trials in children
    • (2000) BMJ , vol.320
    • Kmietowicz, Z.1
  • 22
    • 0034605790 scopus 로고    scopus 로고
    • Clinical trials of medicines in children. US experience shows how to ensure that treatment of children is evidence based
    • (2000) BMJ , vol.321 , pp. 1093-1094
    • Choonara, I.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.